TFA
BSX icon

Transamerica Financial Advisors’s Boston Scientific BSX Stock Holding History

Transamerica Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.1K Sell
2,299
-50,550
-96% -$2.74M 0.01% 585
2026
Q1 		$3.32M Sell
52,849
-2,102
-4% -$168K 0.28% 94
2025
Q4 		$5.24M Sell
54,951
-1,815
-3% -$178K 0.44% 63
2025
Q3 		$5.54M Sell
56,766
-282
-0.5% -$29.2K 0.46% 47
2025
Q2 		$6.13M Sell
57,048
-1,719
-3% -$174K 0.58% 38
2025
Q1 		$5.93M Sell
58,767
-1,116
-2% -$112K 0.6% 34
2024
Q4 		$5.35M Sell
59,883
-1,663
-3% -$146K 0.53% 46
2024
Q3 		$5.16M Sell
61,546
-2,204
-3% -$174K 0.5% 50
2024
Q2 		$4.91M Hold
63,750
– – 0.52% 51
2024
Q1 		$4.37M Buy
63,750
+58,041
+1,017% +$3.73M 0.44% 66
2023
Q4 		$331K Buy
5,709
+5,116
+863% +$273K 0.05% 204
2023
Q3 		$32K Buy
+593
New +$31.1K ﹤0.01% 291
2023
Q1 		– Sell
-12
Closed -$1K – 618
2022
Q4 		$1K Buy
+12
New +$520 ﹤0.01% 437

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Transamerica Financial Advisors's BSX Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its Boston Scientific (BSX) stake by 96% in Q2 2026, selling an estimated $2.74M and leaving 2,299 shares worth $98.1K. The position accounts for 0.01% of the portfolio, ranked #585.

Transamerica Financial Advisors first reported a position in BSX in Q4 2022 and has held it in 13 quarters since. The position peaked at $6.13M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Transamerica Financial Advisors held 2,299 shares of Boston Scientific worth $98.1K as of Q2 2026.
  • Transamerica Financial Advisors sold 50,550 Boston Scientific shares in Q2 2026, an estimated $2.74M.
  • Boston Scientific made up 0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #585 holding.
  • Transamerica Financial Advisors first reported a position in Boston Scientific in Q4 2022 and has held it in 13 quarters since.
  • Transamerica Financial Advisors's Boston Scientific position peaked at $6.13M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.